Saes Getters

Earnings Release • Sep 13, 2023

PRESS RELEASE Milan, September 13, 2023

New approval of half-yearly financial information

SAES Getters S.p.A. informs that the extraordinary Board of Directors of the Company, which was held yesterday evening, 12 September 2023, re-approved the interim consolidated financial report as at June 30, 2023, revising the one previously approved by the Board of Directors held in the morning of the same day.

The change, that did not lead to changes in the financial statements figures, was necessary to describe the notice received from the Federal Trade Commission (FTC) that it has closed its investigation regarding the sale of the Nitinol business for medical applications, occurred after the first approval.

In particular, since this authorization by FTC is considered a decisive element for the purposes of the application of IFRS 5, the Nitinol business was considered a "disposal group held for sale" starting from 12 September 2023, pursuant to the paragraph 12 of IFRS 5 and, therefore, the information required by paragraph 41, letters a), b) and d) of the same principle had been provided in the Notes (previously included only in the Report on operations on a voluntary basis, given the relevance of the transaction).

As previously communicated, the interim consolidated financial statements as at June 30, 2023 will be available on the Company's website (www.saesgetters.com/investor-relations/financial-reports) and on the centralized storage mechanism () within today.

Contacts:

Emanuela Foglia Investor Relations Manager Tel. +39 02 93178 273 E-mail: investor-relations@saes-group.com

Ufficio Stampa Corporate Close to Media Tel. +39 02 70006237 Enrico Bandini E-mail: enrico.bandini@closetomedia.it Simone Bellanova E-mail: simone.bellanova@closetomedia.it